Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genome analysis].

J Schmidtke1

  • 1Institut für Humangenetik, Universitäts-Klinikum Charlottenburg der Freien Universität Berlin.

Arzneimittel-Forschung
|July 1, 1989
PubMed
Summary
This summary is machine-generated.

Only 1% of human genes are mapped, limiting molecular genetic analysis for hereditary disorders. Further gene mapping is crucial for developing diagnostics and therapies for genetic diseases.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The potential benefits of genetic testing in breast and ovarian cancer.

Saudi medical journal·2016
Same author

[Concepts for the return of secondary genetic findings in medical diagnostics and research].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2014
Same author

Health needs assessment for medical genetic services for congenital disorders in middle- and low-income nations.

Journal of community genetics·2013
Same author

International variation in physicians' attitudes towards prophylactic mastectomy - comparison between France, Germany, the Netherlands and the United Kingdom.

European journal of cancer (Oxford, England : 1990)·2013
Same author

Evaluation of Clinical Manifestations in Patients with Severe Lymphedema with and without CCBE1 Mutations.

Molecular syndromology·2013
Same author

[Health insurance companies and medical genetics, what do they want to know? Expert opinions concerning medical genetic services].

Versicherungsmedizin·2012
Same journal

Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

Arzneimittel-Forschung·2013
Same journal

Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

Arzneimittel-Forschung·2013
Same journal

Leave-one-out procedure in the validation of elimination rate constant analysis.

Arzneimittel-Forschung·2012
Same journal

Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

Arzneimittel-Forschung·2012
Same journal

Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

Arzneimittel-Forschung·2012
Same journal

Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

Arzneimittel-Forschung·2012
See all related articles

Area of Science:

  • Human Genetics
  • Molecular Biology
  • Medical Genomics

Context:

  • Currently, a vast majority of human genes remain uncharacterized at the molecular and chromosomal levels.
  • This limited understanding restricts the application of advanced genetic techniques to a small fraction of inherited conditions.

Purpose:

  • To highlight the current state of human gene characterization.
  • To emphasize the necessity of expanding molecular genetic analysis for hereditary disorders.

Summary:

  • Approximately 1% of human genes have been successfully cloned and mapped.
  • This leaves a significant gap in our ability to study and understand most genetic diseases at a molecular level.

Impact:

  • Accelerating gene discovery and mapping is essential for advancing diagnostic capabilities.
  • Enabling the development of targeted molecular therapies for a wider range of genetic disorders.
  • Facilitating a deeper understanding of the genetic basis of human diseases.